Jindong Xie

April 18, 2024

Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer

Abstract Background: The Y-box-binding proteins (YBX) act as a multifunctional role in tumor progression, metastasis, drug resistance by regulating the…

February 11, 2023

Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study

Abstract Introduction: Cancer‐associated fibroblasts (CAFs) are correlated with the immunotherapy response. However, the culprits that link CAFs to immunotherapy resistance…